These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 23280795

  • 1. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.
    Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, Castellani RJ, Mandava P, Kent TA, Simard JM.
    Ann Neurol; 2012 Nov; 72(5):799-806. PubMed ID: 23280795
    [Abstract] [Full Text] [Related]

  • 2. Does inhibiting Sur1 complement rt-PA in cerebral ischemia?
    Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, Colucci M, Gerzanich V.
    Ann N Y Acad Sci; 2012 Sep; 1268():95-107. PubMed ID: 22994227
    [Abstract] [Full Text] [Related]

  • 3. Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke.
    Kunte H, Schmidt S, Eliasziw M, del Zoppo GJ, Simard JM, Masuhr F, Weih M, Dirnagl U.
    Stroke; 2007 Sep; 38(9):2526-30. PubMed ID: 17673715
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke.
    Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V.
    Stroke; 2009 Feb; 40(2):604-9. PubMed ID: 19023097
    [Abstract] [Full Text] [Related]

  • 5. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.
    Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V.
    Nat Med; 2006 Apr; 12(4):433-40. PubMed ID: 16550187
    [Abstract] [Full Text] [Related]

  • 6. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
    Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT, Neonatal Diabetes International Collaborative Group.
    Diabetes Care; 2008 Feb; 31(2):204-9. PubMed ID: 18025408
    [Abstract] [Full Text] [Related]

  • 7. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?
    Leibowitz G, Cerasi E.
    Diabetologia; 1996 May; 39(5):503-14. PubMed ID: 8739909
    [Abstract] [Full Text] [Related]

  • 8. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.
    Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, Keledjian K, Bochicchio G, Gerzanich V.
    J Neurotrauma; 2009 Dec; 26(12):2257-67. PubMed ID: 19604096
    [Abstract] [Full Text] [Related]

  • 9. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P.
    N Engl J Med; 2006 Aug 03; 355(5):456-66. PubMed ID: 16885549
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.
    Meirhaeghe A, Helbecque N, Cottel D, Arveiler D, Ruidavets JB, Haas B, Ferrières J, Tauber JP, Bingham A, Amouyel P.
    Am J Med Genet; 2001 Jun 01; 101(1):4-8. PubMed ID: 11343328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
    Owecki M, Horst-Sikorska W, Kaczmarek M, Słomski R, Sowiński J.
    Pol Arch Med Wewn; 2003 Feb 01; 109(2):143-8. PubMed ID: 12879777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Molecular basis of oral hypoglycemic sulfonylurea action].
    Owecki M, Horst-Sikorska W, Sowiński J.
    Pol Merkur Lekarski; 2003 Nov 01; 15(89):445-8. PubMed ID: 14969140
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4.
    Simard JM, Kahle KT, Gerzanich V.
    J Neurosurg; 2010 Sep 01; 113(3):622-9. PubMed ID: 20035575
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.